Search Results - "Drapalova, J."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet by Touskova, V., Trachta, P., Kavalkova, P., Drapalova, J., Haluzikova, D., Mraz, M., Lacinova, Z., Marek, J., Haluzik, M.

    Published in Molecular and cellular endocrinology (25-09-2012)
    “…► We studied mRNA expression of IGF-1 axis components in monocytes and subcutaneous adipose tissue. ► Type 2 diabetic women had increased IGF-1R mRNA…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance by Moreno-Navarrete, J M, Touskova, V, Sabater, M, Mraz, M, Drapalova, J, Ortega, F, Serrano, M, Catalán, V, Gómez-Ambrosi, J, Ortiz, M R, Pardo, G, Pueyo, N, Ricart, W, Lacinova, Z, Haluzik, M, Frühbeck, G, Fernández-Real, J M

    Published in International Journal of Obesity (01-09-2013)
    “…Objective: Recent studies linked circulating pigment epithelium-derived factor ( PEDF ) to obesity-associated insulin resistance, but the main source of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF‐19 and FGF‐21 in morbidly obese subjects by Haluzíková, D., Lacinová, Z., Kaválková, P., Drápalová, J., Křížová, J., Bártlová, M., Mráz, M., Petr, T., Vítek, L., Kasalický, M., Haluzík, M.

    Published in Obesity (Silver Spring, Md.) (01-07-2013)
    “…Objective Fibroblast growth factor (FGF)‐19 and FGF‐21 are novel metabolic regulators that improve insulin resistance and obesity in rodents. The aim of the…”
    Get full text
    Journal Article
  7. 7

    Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissue by Kotulak, T, Drapalova, J, Lips, M, Lacinova, Z, Kramar, P, Riha, H, Netuka, I, Maly, J, Blaha, J, Lindner, J, Svacina, S, Mraz, M, Haluzik, M

    Published in Physiological research (01-01-2014)
    “…Adipocyte fatty acid binding protein (A-FABP) is a novel adipokine involved in the regulation of lipid and glucose metabolism and inflammation. To evaluate its…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients by Trachta, P., Dostálová, I., Haluzíková, D., Kasalický, M., Kaválková, P., Drápalová, J., Urbanová, M., Lacinová, Z., Mráz, M., Haluzík, M.

    Published in Molecular and cellular endocrinology (05-03-2014)
    “…•Subcutaneous fat of obese exerts a strong chemoattracting profile.•Peripheral monocytes complement this profile with corresponding receptors.•Laparoscopic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity by Maletínská, L., Matyšková, R., Maixnerová, J., Sýkora, D., Pýchová, M., Špolcová, A., Blechová, M., Drápalová, J., Lacinová, Z., Haluzík, M., Železná, B.

    Published in Molecular and cellular endocrinology (22-08-2011)
    “…► Estrogen deficient mice on high fat diet developed metabolic syndrome features. ► Ghrelin antagonist [D-Lys3]GHRP-6 improved metabolic parameters in these…”
    Get full text
    Journal Article
  12. 12

    Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment by Mráz, M, Lacinová, Z, Kaválková, P, Haluzíková, D, Trachta, P, Drápalová, J, Hanušová, V, Haluzík, M

    Published in Physiological research (01-01-2011)
    “…The aim of our study was to measure serum concentrations of fibroblast growth factor 19 (FGF-19) in patients with obesity (OB), obesity and type 2 diabetes…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice by Holubová, M, Spolcová, A, Demianová, Z, Sýkora, D, Fehrentz, J A, Martinez, J, Stofková, A, Jurčovičová, J, Drápalová, J, Lacinová, Z, Haluzík, M, Zelezná, B, Maletínská, L

    Published in Physiological research (01-01-2013)
    “…Ghrelin and agonists of its receptor GHS-R1a are potential substances for the treatment of cachexia. In the present study, we investigated the acute and long…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: the Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-[alpha] Agonist Treatment by Mráz, M, Lacinová, Z, Kaválková, P, Haluzíková, D, Trachta, P, Drápalová, J, Hanusová, V, Haluzík, M

    Published in Physiological research (01-07-2011)
    “…The aim of our study was to measure serum concentrations of fibroblast growth factor 19 (FGF-19) in patients with obesity (OB), obesity and type 2 diabetes…”
    Get full text
    Journal Article